Healthcare Archives

Healthcare Industry News Weekly Wrap-Up: April 25, 2024

// Biotech and Pharma Therapeutics Bristol Myers taps startup to boost cell therapy production April 22, 2024 / Cell Therapy / CAR-T Therapies / Bristol Myers Squibb / Partnership Bristol Myers Squibb has partnered with Cellares, a California-based startup, to...

April 25, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 18, 2024

// Biotech and Pharma Therapeutics Lilly obesity drug shows benefit in sleep disorder study, pointing to new use April 17, 2024 / Eli Lilly / Obesity / Sleep Disorder / GLP-1 / Clinical Trials Fresh clinical trial results for Eli...

April 18, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 11, 2024

// Biotech and Pharma Therapeutics AACR 2024: Getting older younger may be driving rise in early-onset cancers April 8, 2024 / Cancer / AACR As with most common diseases of the developed world, aging is the major risk factor for...

April 11, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 5, 2024

// Biotech and Pharma Therapeutics Following Boehringer’s lead, AstraZeneca ⁠caps monthly out-of-pocket inhaler costs at $35 in the US March 18, 2024 / AstraZeneca / Symbicort / Inhaled Medicines / Asthma AstraZeneca on Monday revealed it’s expanding a savings program...

April 5, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 28, 2024

March 28, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 7, 2024

// Biotech and Pharma Therapeutics RSV vaccines may raise risk of Guillain-Barré syndrome, FDA preliminary analysis finds March 4, 2024 / RSV / Pfizer / GSK / Arexvy After decades of research into respiratory syncytial virus (RSV), Pfizer and GSK’s...

March 7, 2024

Metabolic News Weekly

Metabolic News Weekly: March 5, 2024

Akero’s New MASH Drug Data: Longer Treatment Leads to More Liver Benefit March 4, 2024 / MASH / Drug Development / Liver Disease Akero Therapeutics’ preliminary Phase 2b data show that treatment with its MASH drug, efruxifermin, continued to distance...

March 5, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 29, 2024

// Biotech and Pharma Therapeutics Boehringer Ingelheim’s Liver Drug Data Position It for MASH Clash With Eli Lilly February 26, 2024 / Boehringer Ingelheim / Liver / New Drug / MASH / Eli Lilly Preliminary Phase 2 results show 83%...

February 29, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 22, 2024

// Biotech and Pharma Therapeutics Phage therapy: Researchers sharpen another arrow in the quiver against antibiotic resistance February 20, 2024 / Antibiotic Resistance / New Drug “It just got so frustrating over the years because we couldn’t find the source,...

February 22, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 16, 2024

// Biotech and Pharma Therapeutics Sage Touts Strong Launch for Postpartum Depression Drug Zurzuvae February 15, 2024 / Depression / Postpartum / Women’s Health / Sage Therapeutics Despite launching with just days left in 2023, Sage Therapeutics’ postpartum depression therapy...

February 16, 2024

1 2 … 8 9

Tag: Healthcare

Healthcare Industry News Weekly Wrap-Up: April 25, 2024

Healthcare Industry News Weekly Wrap-Up: April 18, 2024

Healthcare Industry News Weekly Wrap-Up: April 11, 2024

Healthcare Industry News Weekly Wrap-Up: April 5, 2024

Healthcare Industry News Weekly Wrap-Up: March 28, 2024

Healthcare Industry News Weekly Wrap-Up: March 7, 2024

Metabolic News Weekly: March 5, 2024

Healthcare Industry News Weekly Wrap-Up: February 29, 2024

Healthcare Industry News Weekly Wrap-Up: February 22, 2024

Healthcare Industry News Weekly Wrap-Up: February 16, 2024

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy⁺

About Vault

Tag: Healthcare

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy+

About Vault

Strategy⁺